source: main/adopters/nj/trunk/src/main/webapps/doh-shad-content/xml/indicator/profile/CervCancer.xml @ 22934

Last change on this file since 22934 was 22934, checked in by Maria Baron, 15 months ago

updated indicators and removed 3 from community profiles

File size: 7.9 KB
1<?xml version="1.0" encoding="ISO-8859-1"?>
3<INDICATOR name="CervCancer">
4        <NAME>CervCancer</NAME>
5        <DESCRIPTION>cervical cancer</DESCRIPTION>
7        <TITLE>Incidence of Cervical Cancer</TITLE>
8        <DEFINITION>Age-adjusted incidence rate of invasive cervical cancer in females per 100,000 standard population.
9ICD-O-3 codes: C53.0-C53.9 (excl. types 9590-9992)</DEFINITION>
10        <NUMERATOR>Number of new cases of invasive cervical cancer diagnosed among females</NUMERATOR>
11        <DENOMINATOR>Total number of females in the population</DENOMINATOR>
12        <DATA_NOTE>This is Healthy New Jersey 2020 objective CA-10.</DATA_NOTE>
13        <DATA_SOURCE_DATE>05/07/2021</DATA_SOURCE_DATE>
14        <WHY_IMPORTANT>Cervical cancer is the easiest gynecologic cancer to prevent with regular screening tests and followup.  It also is highly curable when found and treated early.[ ^1^]</WHY_IMPORTANT>
16        <OTHER_OBJECTIVE_DESCRIPTION>'''Updated Healthy New Jersey 2020 Objective CA-10''': Reduce the age-adjusted incidence rate of invasive uterine cervical cancer in females per 100,000 standard population to 7.2 for the total population, 6.4 among Whites, 9.0 among Blacks, 9.8 among Hispanics, and 3.2 among Asians.
18'''Original Healthy New Jersey 2020 Objective CA-10''': Reduce the age-adjusted incidence rate of invasive uterine cervical cancer in females per 100,000 standard population to 7.2 for the total population, 7.1 among Whites, 9.0 among Blacks, 11.6 among Hispanics, and 6.3 among Asians.</OTHER_OBJECTIVE_DESCRIPTION>
21        <RESOURCES_REFERENCES_LINKS>1. [ CDC Cervical Cancer Fact Sheet]
23CDC Cervical Cancer Info:  []</RESOURCES_REFERENCES_LINKS>
25        <OWNER_USER_ID>mbaron</OWNER_USER_ID>
27        <STATUS_DATE>05/07/2021</STATUS_DATE>
28        <NOTE>edited by MLB 5/17/11
29approved by Stasia Burger 5/18/11
301998-2010 verified/provided by Stasia and entered by MLB 1/29/14
312009-2012 data provided by Stasia Burger and entered by MLB 6/8/15
32Reviewed and OK'd by Stasia 6/15/15
33Reviewed and approved by Stasia Burger 8/2/16, 5/16/18
341/17/20 (KO): Enhancements to "Related Indicators" (reviewed by Stasia Burger and the DP17-1701 Leadership Team)</NOTE>
35        <SORT_ORDER>282</SORT_ORDER>
37        <MODIFIED_DATE>05/07/2021</MODIFIED_DATE>
38        <MODIFIED_DESCRIPTION>Status changed by: mbaron</MODIFIED_DESCRIPTION>
39        <PUBLISHED_DATE>05/07/2021</PUBLISHED_DATE>
40        <HEALTHY_PEOPLE_OBJECTIVE name="C-10">
41                <NAME>C-10</NAME>
42                <TITLE>Reduce invasive uterine cervical cancer</TITLE>
43                <FOCUS_AREA_NAME>C</FOCUS_AREA_NAME>
45                <DESCRIPTION>Reduce invasive uterine cervical cancer</DESCRIPTION>
46                <US_TARGET>7.2 new cases per 100,000 females (age-adjusted)</US_TARGET>
47                <STATE_TARGET>7.2 new cases per 100,000 females (age-adjusted)</STATE_TARGET>
48                <SORT_ORDER>121</SORT_ORDER>
49                <MODIFIED_DATE>06/08/2015</MODIFIED_DATE>
50                <ACTIVE_FLAG>x</ACTIVE_FLAG>
52        <DATA_SOURCES/>
53        <RELATIONS>
54                <RELATION name="SystemFactors">
55                        <NAME>SystemFactors</NAME>
56                        <TITLE>Health Care System Factors</TITLE>
57                        <TEXT>Since September 2014, the [ United States Preventive Services Task Force] has recommended intensive '''behavioral counseling''' for all sexually active adolescents and for adults who are at increased risk for [ sexually transmitted infections (STIs)].  [Last reviewed: 1/26/20]
59Since October 2019, the CDC [ Advisory Committee on Immunization Practices] has recommended 1) routine '''HPV vaccination''' of children by 11 or 12 years of age (starting as early as age 9), 2) vaccination for females aged 13 through 26 years and males aged 13 through 21 years not adequately vaccinated previously, and 3) vaccination through age 26 years for gay, bisexual, and other men who have sex with men, transgender people, and for immunocompromised persons (including those with HIV infection) not adequately vaccinated previously.  [Last reviewed: 1/26/20]
61According to the [ National Cancer Institute], regular '''screening with the Papanicolaou (Pap) test''' decreases cervical cancer incidence and mortality by at least 80%, while '''HPV-based screening''' provides 60% to 70% greater protection against invasive cervical carcinoma compared with cytology. [Last reviewed: 1/26/20]</TEXT>
62                        <RELATED_INDICATORS>
63                                <RELATED_INDICATOR>
64                                        <NAME>PapTest</NAME>
65                                        <TITLE>Self-Reported Cervical Cancer Screening</TITLE>
66                                        <DEFAULT_INDICATOR_VIEW_NAME>PapTest.Year2</DEFAULT_INDICATOR_VIEW_NAME>
67                                </RELATED_INDICATOR>
68                        </RELATED_INDICATORS>
69                </RELATION>
70                <RELATION name="RiskFactors">
71                        <NAME>RiskFactors</NAME>
72                        <TITLE>Risk Factors</TITLE>
73                        <TEXT>According to the [ National Cancer Institute], almost all cases of cervical cancer are caused by '''infection with high-risk types of the human papillomavirus (HPV)''', and '''HPV vaccination''' protects against the HPV types that most often cause cervical cancer. Any woman who is sexually active is at risk for HPV infection, but the risk for both HPV infection and cervical cancer increases with having '''sexual relations at an early age''' and having an '''increasing number of sexual partners'''. Factors associated with increased risk of cervical cancer among HPV-infected women include '''giving birth to many children''', '''cigarette smoking''' (both active and passive), and long-term use of '''oral contraceptives'''.  [Last reviewed:  1/26/20]</TEXT>
74                        <RELATED_INDICATORS>
75                                <RELATED_INDICATOR>
76                                        <NAME>CigSmokAdlt</NAME>
77                                        <TITLE>Cigarette Smoking Among Adults</TITLE>
78                                        <DEFAULT_INDICATOR_VIEW_NAME>CigSmokAdlt.Year2</DEFAULT_INDICATOR_VIEW_NAME>
79                                </RELATED_INDICATOR>
80                                <RELATED_INDICATOR>
81                                        <NAME>CigSmokHS</NAME>
82                                        <TITLE>Cigarette Use among High School Students</TITLE>
83                                        <DEFAULT_INDICATOR_VIEW_NAME>CigSmokHS.NJvUS</DEFAULT_INDICATOR_VIEW_NAME>
84                                </RELATED_INDICATOR>
85                                <RELATED_INDICATOR>
86                                        <NAME>CigSmokMS</NAME>
87                                        <TITLE>Cigarette Use among Middle School Students</TITLE>
88                                        <DEFAULT_INDICATOR_VIEW_NAME>CigSmokMS.Year</DEFAULT_INDICATOR_VIEW_NAME>
89                                </RELATED_INDICATOR>
90                        </RELATED_INDICATORS>
91                </RELATION>
92                <RELATION name="HealthStatus">
93                        <NAME>HealthStatus</NAME>
94                        <TITLE>Health Status Outcomes</TITLE>
95                        <TEXT>Using data from SEER 18 (2009-2015), the [ National Cancer Institute] found the five-year '''relative survival''' for women diagnosed with cervical cancer to be approximately 66% overall.  [Last reviewed:  1/27/20]</TEXT>
96                        <RELATED_INDICATORS>
97                                <RELATED_INDICATOR>
98                                        <NAME>CervCADth</NAME>
99                                        <TITLE>Deaths due to Cervical Cancer</TITLE>
100                                        <DEFAULT_INDICATOR_VIEW_NAME>CervCaDth.Trend</DEFAULT_INDICATOR_VIEW_NAME>
101                                </RELATED_INDICATOR>
102                        </RELATED_INDICATORS>
103                </RELATION>
104        </RELATIONS>
105        <INDICATOR_VIEWS>
106                <INDICATOR_VIEW>
107                        <NAME>CervCancer.RaceEth</NAME>
108                        <TITLE>Age-adjusted Incidence Rate of Cervical Cancer,</TITLE>
109                        <SUB_TITLE>by Race/Ethnicity, New Jersey,</SUB_TITLE>
110                        <PERIOD_TITLE>2010-2018 (preliminary)</PERIOD_TITLE>
111                        <Y_TITLE>Age-adjusted Incidence Rate per 100,000 Females</Y_TITLE>
112                </INDICATOR_VIEW>
113        </INDICATOR_VIEWS>
Note: See TracBrowser for help on using the repository browser.